Cargando…
Diagnostic performance of CO-RADS for COVID-19: a systematic review and meta-analysis
OBJECTIVES: To investigate the diagnostic performance of the coronavirus disease 2019 (COVID-19) Reporting and Data System (CO-RADS) for detecting COVID-19. METHODS: We searched PubMed, EMBASE, MEDLINE, Web of Science, Cochrane Library, and Scopus database until September 21, 2021. Statistical analy...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961267/ https://www.ncbi.nlm.nih.gov/pubmed/35348865 http://dx.doi.org/10.1007/s00330-022-08576-y |
_version_ | 1784677560880201728 |
---|---|
author | Liu, Guina Chen, Yuntian Runa, A Liu, Jiaming |
author_facet | Liu, Guina Chen, Yuntian Runa, A Liu, Jiaming |
author_sort | Liu, Guina |
collection | PubMed |
description | OBJECTIVES: To investigate the diagnostic performance of the coronavirus disease 2019 (COVID-19) Reporting and Data System (CO-RADS) for detecting COVID-19. METHODS: We searched PubMed, EMBASE, MEDLINE, Web of Science, Cochrane Library, and Scopus database until September 21, 2021. Statistical analysis included data pooling, forest plot construction, heterogeneity testing, meta-regression, and subgroup analyses. RESULTS: We included 24 studies with 8382 patients. The pooled sensitivity and specificity and the area under the curve (AUC) of CO-RADS ≥ 3 for detecting COVID-19 were 0.89 (95% confidence interval (CI) 0.85–0.93), 0.68 (95% CI 0.60–0.75), and 0.87 (95% CI 0.84–0.90), respectively. The pooled sensitivity and specificity and AUC of CO-RADS ≥ 4 were 0.83 (95% CI 0.79–0.87), 0.84 (95% CI 0.78–0.88), and 0.90 (95% CI 0.87–0.92), respectively. Cochran’s Q test (p < 0.01) and Higgins I(2) heterogeneity index revealed considerable heterogeneity. Studies with both symptomatic and asymptomatic patients had higher specificity than those with only symptomatic patients using CO-RADS ≥ 3 and CO-RADS ≥ 4. Using CO-RADS ≥ 4, studies with participants aged < 60 years had higher sensitivity (0.88 vs. 0.80, p = 0.02) and lower specificity (0.77 vs. 0.87, p = 0.01) than studies with participants aged > 60 years. CONCLUSIONS: CO-RADS has favorable performance in detecting COVID-19. CO-RADS ≥ 3/4 might be applied as cutoff values given their high sensitivity and specificity. However, there is a need for more well-designed studies on CO-RADS. KEY POINTS: • CO-RADS shows a favorable performance in detecting COVID-19. • CO-RADS ≥ 3 had a high sensitivity 0.89 (95% CI 0.85–0.93), and it may prove advantageous in screening the potentially infected people to prevent the spread of COVID-19. • CO-RADS ≥ 4 had high specificity 0.84 (95% CI 0.78–0.88) and may be more suitable for definite diagnosis of COVID-19. |
format | Online Article Text |
id | pubmed-8961267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-89612672022-03-29 Diagnostic performance of CO-RADS for COVID-19: a systematic review and meta-analysis Liu, Guina Chen, Yuntian Runa, A Liu, Jiaming Eur Radiol Chest OBJECTIVES: To investigate the diagnostic performance of the coronavirus disease 2019 (COVID-19) Reporting and Data System (CO-RADS) for detecting COVID-19. METHODS: We searched PubMed, EMBASE, MEDLINE, Web of Science, Cochrane Library, and Scopus database until September 21, 2021. Statistical analysis included data pooling, forest plot construction, heterogeneity testing, meta-regression, and subgroup analyses. RESULTS: We included 24 studies with 8382 patients. The pooled sensitivity and specificity and the area under the curve (AUC) of CO-RADS ≥ 3 for detecting COVID-19 were 0.89 (95% confidence interval (CI) 0.85–0.93), 0.68 (95% CI 0.60–0.75), and 0.87 (95% CI 0.84–0.90), respectively. The pooled sensitivity and specificity and AUC of CO-RADS ≥ 4 were 0.83 (95% CI 0.79–0.87), 0.84 (95% CI 0.78–0.88), and 0.90 (95% CI 0.87–0.92), respectively. Cochran’s Q test (p < 0.01) and Higgins I(2) heterogeneity index revealed considerable heterogeneity. Studies with both symptomatic and asymptomatic patients had higher specificity than those with only symptomatic patients using CO-RADS ≥ 3 and CO-RADS ≥ 4. Using CO-RADS ≥ 4, studies with participants aged < 60 years had higher sensitivity (0.88 vs. 0.80, p = 0.02) and lower specificity (0.77 vs. 0.87, p = 0.01) than studies with participants aged > 60 years. CONCLUSIONS: CO-RADS has favorable performance in detecting COVID-19. CO-RADS ≥ 3/4 might be applied as cutoff values given their high sensitivity and specificity. However, there is a need for more well-designed studies on CO-RADS. KEY POINTS: • CO-RADS shows a favorable performance in detecting COVID-19. • CO-RADS ≥ 3 had a high sensitivity 0.89 (95% CI 0.85–0.93), and it may prove advantageous in screening the potentially infected people to prevent the spread of COVID-19. • CO-RADS ≥ 4 had high specificity 0.84 (95% CI 0.78–0.88) and may be more suitable for definite diagnosis of COVID-19. Springer Berlin Heidelberg 2022-03-29 2022 /pmc/articles/PMC8961267/ /pubmed/35348865 http://dx.doi.org/10.1007/s00330-022-08576-y Text en © The Author(s), under exclusive licence to European Society of Radiology 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Chest Liu, Guina Chen, Yuntian Runa, A Liu, Jiaming Diagnostic performance of CO-RADS for COVID-19: a systematic review and meta-analysis |
title | Diagnostic performance of CO-RADS for COVID-19: a systematic review and meta-analysis |
title_full | Diagnostic performance of CO-RADS for COVID-19: a systematic review and meta-analysis |
title_fullStr | Diagnostic performance of CO-RADS for COVID-19: a systematic review and meta-analysis |
title_full_unstemmed | Diagnostic performance of CO-RADS for COVID-19: a systematic review and meta-analysis |
title_short | Diagnostic performance of CO-RADS for COVID-19: a systematic review and meta-analysis |
title_sort | diagnostic performance of co-rads for covid-19: a systematic review and meta-analysis |
topic | Chest |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961267/ https://www.ncbi.nlm.nih.gov/pubmed/35348865 http://dx.doi.org/10.1007/s00330-022-08576-y |
work_keys_str_mv | AT liuguina diagnosticperformanceofcoradsforcovid19asystematicreviewandmetaanalysis AT chenyuntian diagnosticperformanceofcoradsforcovid19asystematicreviewandmetaanalysis AT runaa diagnosticperformanceofcoradsforcovid19asystematicreviewandmetaanalysis AT liujiaming diagnosticperformanceofcoradsforcovid19asystematicreviewandmetaanalysis |